7Q5-43726-47951
2 vaccinations
13 coded responses
20 check-ins
13 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 300 / GA
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
-
2021-01-28
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Diarrhea · Be unable to workFree text: I am a patient with GI neuroendocrine Cancer and short gut syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Diarrhea · Be unable to workAdult check-in
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Diarrhoea — Feeling: Good · Diarrhea · Be unable to workFree text: I have chronic diarrhea due to GI-NET CAMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — day 7, dose 1MedDRA: Diarrhoea — Feeling: Good · Diarrhea · Be unable to workFree text: Pt with chronic NET CA related diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
-
2021-02-15
Dose 2 — Pfizer-BioNTech
-
2021-02-15
Survey response — day 0, dose 2MedDRA: Pre-existing disease — Feeling: Good · Diarrhea · Be unable to workFree text: GI-NET CA & Short gut syndrome secondary to related abdominal surgery to reduce Tumor burdenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Diarrhoea, Pre-existing disease — Feeling: Good · Diarrhea · Be unable to workFree text: I have chronic diarrhea due to GI-NET CAMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Diarrhea · Be unable to workFree text: Related to GI-NET CAMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Diarrhea · Be unable to workFree text: Chronic conditionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Diarrhoea, Pre-existing disease — Feeling: Good · Joint pains, Diarrhea · Be unable to workFree text: Diarrhea & joint aches/pains are related to chronic GI NET CAMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Diarrhoea, Pre-existing disease — Feeling: Good · Diarrhea · Be unable to workFree text: Chronic diarrhea due to GI CAMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Survey response — day 7, dose 2MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Diarrhea · Be unable to workFree text: Above are chronicMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
-
2021-03-08
Survey response — day 21, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 1.) Cat bite L hand2.) evidence of small PE on CT SCAN 3/1/2021MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-17
-
2021-03-23
Survey response — day 35, dose 2MedDRA: Diarrhoea, Unevaluable event — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professionalFree text: Symptoms: More difficulty regulating diarrhea frequency & urgency · Healthcare visit (other): On Phase 1 clinical trial for Tidutamab (biphasic monoclonal antibody trialMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-30
- 2021-05-17
- 2021-08-18
-
2022-02-18
Survey response — 12 months, dose 2MedDRA: Biopsy breast abnormal, Intraductal proliferative breast lesion, Paget's disease of nipple, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Appearance of now biopsy dx of DISC/Pagets of R breast · Healthcare visit (other): Diagnostic tissue biopsy, R nipple & areolaMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): I am a patient with GI neuroendocrine Cancer and short gut syndrome
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): I have chronic diarrhea due to GI-NET CA
Release 3 — day 7, dose 1
Systemic reaction (other): Pt with chronic NET CA related diarrhea
Release 4 — day 0, dose 2
Systemic reaction (other): GI-NET CA & Short gut syndrome secondary to related abdominal surgery to reduce Tumor burden
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): I have chronic diarrhea due to GI-NET CA
Systemic reaction (other): Related to GI-NET CA
Systemic reaction (other): Chronic condition
Systemic reaction (other): Diarrhea & joint aches/pains are related to chronic GI NET CA
Systemic reaction (other): Chronic diarrhea due to GI CA
Release 4 — day 7, dose 2
Systemic reaction (other): Above are chronic
Release 5 — day 21, dose 2
Symptoms: 1.) Cat bite L hand2.) evidence of small PE on CT SCAN 3/1/2021
Release 6 — day 35, dose 2
Symptoms: More difficulty regulating diarrhea frequency & urgency
Healthcare visit (other): On Phase 1 clinical trial for Tidutamab (biphasic monoclonal antibody trial
Release 11 — 12 months, dose 2
Symptoms: Appearance of now biopsy dx of DISC/Pagets of R breast
Healthcare visit (other): Diagnostic tissue biopsy, R nipple & areola
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Biopsy breast abnormal | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Intraductal proliferative breast lesion | · | · | ✓ |
| SD | Paget's disease of nipple | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Diarrhoea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release